I studied a patent[1] filed by National Institute of Health. The patent application talks about the recent study that has established that passive immunotherapy

I studied a patent[1] filed by National Institute of Health. The patent application talks about the recent study that has established that passive immunotherapy is a tractable approach to Ebola virus treatment pre- and post-exposure. The invention provides an isolated humanized [2] glycoprotein pre-fusion core that has more than 95% similarity to a human antibody framework region. It also comprises of the different heavy chain and light chain CDR sequences. [1] https://greybmusings.wordpress.com/2014/12/11/us-health-dept-files-patent-for-improved-ebola-treatment/ https://greybmusings.wordpress.com/2014/12/11/us-health-dept... [2] http://en.wikipedia.org/wiki/Humanized_antibody http://en.wikipedia.org/wiki/Humanized_antibody